Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837798 · ClinicalTrials.gov registry record
RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 5,379
- Enrollment target
NCT00837798 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 5,379 participants.
The verdict
NCT00837798 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 5,379 participants
- Enrollment target
Study Summary
The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
Interventions
- DEVICE CRM Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,379 participants |
| Start Date | 2006-10 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00837798
The ClinicalTrials.gov registry entry for NCT00837798 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRM Device is the first listed.
NCT00837798 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00837798 about?
NCT00837798 is a clinical study titled "RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population". The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
What is the current status of trial NCT00837798?
This trial is currently completed. The enrollment target is 5,379 participants. The study started on 2006-10. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00837798?
The interventions under investigation include: CRM Device (DEVICE).
Who is sponsoring clinical trial NCT00837798?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.